Developer docs
API playgroundTry for free, no card

Search company profiles

VIVES Funds

Full company profile

uuid0005qhs

Namestring
VIVES Funds
Company typeenum
Private
Founded yearint
2004
Descriptiontext

VIVES Funds is a seed capital fund manager headquartered in Wavre, Belgium, founded in 2004. Per the available firmographic description, the firm operates as a seed-stage investor, deploying early capital into early-stage companies. The organization is structured as a small boutique with 1–10 employees, consistent with a specialist European seed fund rather than a multi-strategy platform.

The firm's business model is that of a venture capital fund manager: it raises capital from limited partners, deploys that capital into seed-stage portfolio companies, and earns revenue through management fees on committed/invested capital plus carried interest on profitable realizations. As a Belgium-based manager, it operates within the EU's AIFM regulatory framework for alternative investment fund managers.

The source data is sparse beyond the firmographic profile: the company website (vivesfund.com) returned only a loader/verification page at time of capture, and product, customer, technology, team, investment, partnership, and pricing details are all empty. Consequently, fund vintage count, AUM, sector focus, portfolio composition, LP base, and key personnel cannot be characterized from the input. The investment thesis, stage criteria, ticket size, and value-add beyond capital are also not documented in the available material.

Short descriptiontext

VIVES Funds is a Belgium-based (Wavre) seed capital fund manager founded in 2004, deploying early-stage capital with a small boutique team of 1–10 employees. The firm operates within the EU AIFM regulatory framework serving limited partner investors.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWavre, Belgium
HQ citystring
Wavre
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
seed capital, venture capital, early-stage investment, startup funding, private equity
NAICS code2 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Seed Capital Investment
No data
Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

VIVES Funds is a seed capital fund that provides early-stage equity financing to startups. Operating from Wavre, Belgium, the fund targets young companies in need of initial capital to develop and commercialize their offerings. Its core activity consists of deploying seed-stage investments in exchange for equity stakes.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Seed Capital Investment
CategoryVenture Capital / Seed Funding
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

UK-based seed-stage investor focused on Europe. Comparable as a dedicated seed fund targeting founder-led companies at earliest stages.

TypeDirect peer
Description

London-based early-stage venture firm writing seed and Series A cheques into European tech startups. Comparable stage, geography, and cheque size profile.

TypeDirect peer
Description

One of Europe's longest-standing early-stage venture firms, founded in 1997, investing from seed to Series B. Comparable as a long-duration European seed/early-stage specialist.

TypeDirect peer
Description

European seed-stage VC investing in product-led companies. Comparable as a small, specialist European seed manager.

TypeDirect peer
Description

London-based seed-stage venture firm investing across Europe. Closest direct comparable to VIVES given shared focus on early/seed investing and pan-European deal sourcing.

TypeRegional player
Description

Belgian regional investment company providing venture and growth capital to Flemish companies. Comparable as a Belgium-based investor active in early-stage capital, though not exclusively seed-stage.

TypeBroad incumbent
Description

Major European-headquartered venture firm investing from seed to growth. Comparable as a European venture investor, but at meaningfully larger scale and broader stage range.

TypeRegional player
Description

German publicly-backed seed investor for technology startups. Comparable early-stage investor operating in continental Europe, though primarily Germany-focused rather than Benelux.

TypeDirect peer
Description

London-based early-stage VC focused on European enterprise/SaaS. Comparable as a European-focused fund writing cheques at seed and Series A.

TypeDirect peer
Description

Vienna-based early-stage venture firm with sector-focused funds. Comparable seed/Series A European investor with similar stage focus and continental European footprint.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment11 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VIVES Funds

Venture Capital / Seed Capital Investmentvivesfund.com/en

VIVES Funds is a Belgium-based (Wavre) seed capital fund manager founded in 2004, deploying early-stage capital with a small boutique team of 1–10 employees. The firm operates within the EU AIFM regulatory framework serving limited partner investors.

What VIVES Funds does

VIVES Funds is a seed capital fund manager headquartered in Wavre, Belgium, founded in 2004. Per the available firmographic description, the firm operates as a seed-stage investor, deploying early capital into early-stage companies. The organization is structured as a small boutique with 1–10 employees, consistent with a specialist European seed fund rather than a multi-strategy platform.

The firm's business model is that of a venture capital fund manager: it raises capital from limited partners, deploys that capital into seed-stage portfolio companies, and earns revenue through management fees on committed/invested capital plus carried interest on profitable realizations. As a Belgium-based manager, it operates within the EU's AIFM regulatory framework for alternative investment fund managers.

The source data is sparse beyond the firmographic profile: the company website (vivesfund.com) returned only a loader/verification page at time of capture, and product, customer, technology, team, investment, partnership, and pricing details are all empty. Consequently, fund vintage count, AUM, sector focus, portfolio composition, LP base, and key personnel cannot be characterized from the input. The investment thesis, stage criteria, ticket size, and value-add beyond capital are also not documented in the available material.

VIVES Funds firmographics

Firmographics
Name
VIVES Funds
Website
https://www.vivesfund.com/en/
Company type
Private
Founded year
2004
Headcount range
1–10 employees
Short description
VIVES Funds is a Belgium-based (Wavre) seed capital fund manager founded in 2004, deploying early-stage capital with a small boutique team of 1–10 employees. The firm operates within the EU AIFM regulatory framework serving limited partner investors.
Ownership category
akta.pro rank

Where VIVES Funds is headquartered

Location

Headquarters

HQ city
Wavre
HQ country
Belgium
HQ region
Europe

Markets served

VIVES Funds business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

VIVES Funds product offering

Product offering

Core offering

VIVES Funds is a seed capital fund that provides early-stage equity financing to startups. Operating from Wavre, Belgium, the fund targets young companies in need of initial capital to develop and commercialize their offerings. Its core activity consists of deploying seed-stage investments in exchange for equity stakes.

Differentiator

Problem solved

Functional benefit

Products and services

  • Seed Capital Investment

Companies that use VIVES Funds

Customer profile

Ideal customer profiles1 record

VIVES Funds technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

VIVES Funds partnerships and signals

Strategic signal

Recent moves1 record

VIVES Funds competitors and assessment

Company assessment

Direct peers

  • LocalGlobe: UK-based seed-stage investor focused on Europe. Comparable as a dedicated seed fund targeting founder-led companies at earliest stages.
  • Hoxton Ventures: London-based early-stage venture firm writing seed and Series A cheques into European tech startups. Comparable stage, geography, and cheque size profile.
  • Earlybird Venture Capital: One of Europe's longest-standing early-stage venture firms, founded in 1997, investing from seed to Series B. Comparable as a long-duration European seed/early-stage specialist.
  • Connect Ventures: European seed-stage VC investing in product-led companies. Comparable as a small, specialist European seed manager.
  • Seedcamp: London-based seed-stage venture firm investing across Europe. Closest direct comparable to VIVES given shared focus on early/seed investing and pan-European deal sourcing.
  • Notion Capital: London-based early-stage VC focused on European enterprise/SaaS. Comparable as a European-focused fund writing cheques at seed and Series A.
  • Speedinvest: Vienna-based early-stage venture firm with sector-focused funds. Comparable seed/Series A European investor with similar stage focus and continental European footprint.

Regional players

  • PMV (Participatiemaatschappij Vlaanderen): Belgian regional investment company providing venture and growth capital to Flemish companies. Comparable as a Belgium-based investor active in early-stage capital, though not exclusively seed-stage.
  • HTGF (High-Tech Gründerfonds): German publicly-backed seed investor for technology startups. Comparable early-stage investor operating in continental Europe, though primarily Germany-focused rather than Benelux.

Broad incumbents

  • Index Ventures: Major European-headquartered venture firm investing from seed to growth. Comparable as a European venture investor, but at meaningfully larger scale and broader stage range.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Customer concentration

VIVES Funds financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VIVES Funds leadership team

Management profile

Number of profiles

VIVES Funds funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VIVES Funds M&A and investment

M&A and investment

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIVES Funds

What does VIVES Funds do?

VIVES Funds is a seed capital fund that provides early-stage equity financing to startups. Operating from Wavre, Belgium, the fund targets young companies in need of initial capital to develop and commercialize their offerings. Its core activity consists of deploying seed-stage investments in exchange for equity stakes.

When was VIVES Funds founded?

VIVES Funds was founded in 2004. It employs 1 to 10 people.

Where is VIVES Funds based?

VIVES Funds is headquartered in Wavre, Belgium, in the Europe region.

Who are VIVES Funds's main competitors?

Direct peers on record are LocalGlobe, Hoxton Ventures, Earlybird Venture Capital, Connect Ventures, Seedcamp, Notion Capital and Speedinvest. Regional players are PMV (Participatiemaatschappij Vlaanderen) and HTGF (High-Tech Gründerfonds). Index Ventures is listed as a broad incumbent.

Does VIVES Funds have an API?

No public API is recorded for VIVES Funds.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmafiaBelgium’s Novadip Biosciences Raises €10.4M to Fund Pivotal Clinical Trial and Unlock EIB Loan TrancheNovadip Biosciences closed a €10.4 million convertible financing round led by New Science Ventures, bringing total convertible financing to €20 million since June 2025. The funds will support completion of a pivotal Phase 3 trial of NVD003 for congenital pseudarthrosis of the tibia and prepare for a US BLA. The company aims to obtain market authorization by 2028.GenengnewsBacked by $165M, Bionyra Pharma Launches to Advance Inflammatory Disease BiologicsBionyra Pharma, co-founded by Frédéric Marrache, launched after raising $165 million in a Series A led by Jeito Capital and Sofinnova Partners. The company is developing three anti-inflammatory biologics, including TL1A and IL-25 antibodies, with two assets licensed from TrueLab Biopharmaceutical. Funds will support advancing these programs toward new treatment options.startupticker.chNUCLIDIUM's Series B reaches CHF 105 million with latest extensionNUCLIDIUM closed an oversubscribed CHF 26 million Series B extension, bringing the round to CHF 105 million. The financing will advance its copper-based radiotheranostics programs into expanded Phase 1/2 trials and scale global manufacturing. Lead programs NU101 and NU201 are advancing in metastatic prostate and breast cancer.StartbaseNUCLIDIUM expands Series B to 105 million Swiss francsNuclidium expanded its Series B financing to 105 million Swiss francs, adding 26 million from existing and new investors. The funds will support copper-based radiotheranostics programs NU101 and NU201, which are set to start therapeutic phase 1/2a trials this year. The company also plans to expand its production network.